- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 31-07-2026: Press Release
31-07-2026 | 05:08 pm
31-07-2026 | 05:08 pm
Lupin received US FDA approval for Diazepam Injection USP, 10 mg/2 mL, Single-Dose Prefilled Syringes. Indicated for anxiety, this product had estimated annual U.S. sales of USD 77.9 million, presenting a significant new market opportunity for the company.
No comments yet. Be the first to comment!